This issue of PET Clinics focuses on Theranostics and is edited by Drs. Ali Gholamrezanezhad and Hojjat Ahmadzadehfar. Articles will include: Good Clinical Practice for Theranostics; Theranostics in Neuroendocrine Tumors; Neuroendocrine Tumors: Imaging Perspective; Prostate Cancer Theranostics: From Target Description to Imaging; Prostate Cancer Theranostics: PSMA-targeted Therapy; Theranostics in Brain Tumors; Theranostics in Neuroblastoma; Theranostics in Thyroid Cancer; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. CME Accreditation Page - p. xiii 8. General Concepts in Theranostics - p. 313 9. An Impressive Approach in Nuclear Medicine: Theranostics - p. 327 10. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging - p. 341 11. Neuroendocrine Tumors: Imaging Perspective - p. 353 12. Theragnostics in Neuroendocrine Tumors - p. 365 13. Theranostics in Thyroid Cancer - p. 375 14. Prostate Cancer Theranostics: From Target Description to Imaging - p. 383 15. Prostate Cancer Theranostics: PSMA Targeted Therapy - p. 391 16. Theranostics in Brain Tumors - p. 397 17. Theranostics in Neuroblastoma - p. 419 18. Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders - p. 429 19. Theranostic Agents in Musculoskeletal Disorders - p. 441
This issue of PET Clinics focuses on Theranostics and is edited by Drs. Ali Gholamrezanezhad and Hojjat Ahmadzadehfar. Articles will include: Good Clinical Practice for Theranostics; Theranostics in Neuroendocrine Tumors; Neuroendocrine Tumors: Imaging Perspective; Prostate Cancer Theranostics: From Target Description to Imaging; Prostate Cancer Theranostics: PSMA-targeted Therapy; Theranostics in Brain Tumors; Theranostics in Neuroblastoma; Theranostics in Thyroid Cancer; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. CME Accreditation Page - p. xiii 8. General Concepts in Theranostics - p. 313 9. An Impressive Approach in Nuclear Medicine: Theranostics - p. 327 10. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging - p. 341 11. Neuroendocrine Tumors: Imaging Perspective - p. 353 12. Theragnostics in Neuroendocrine Tumors - p. 365 13. Theranostics in Thyroid Cancer - p. 375 14. Prostate Cancer Theranostics: From Target Description to Imaging - p. 383 15. Prostate Cancer Theranostics: PSMA Targeted Therapy - p. 391 16. Theranostics in Brain Tumors - p. 397 17. Theranostics in Neuroblastoma - p. 419 18. Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders - p. 429 19. Theranostic Agents in Musculoskeletal Disorders - p. 441
